Log in or Sign up for Free to view tailored content for your specialty!
Neurorehabilitation News
Older men at greater risk for skull fracture after blunt head trauma
Men aged 65 years and older had a significantly higher rate of skull fracture compared with women after blunt head trauma, mostly because of falls, according to a study from The American Journal of Emergency Medicine.
Visual artistic creativity in FTD may be linked to disease onset, genetics, environment
The emergence of visual artistic creativity among those with frontotemporal dementia may be linked to early lesion-induced activation of the visual cortex and may depend on environment or genetics, according to research presented in JAMA Neurology.
Log in or Sign up for Free to view tailored content for your specialty!
Successful harvest of psilocybin mushrooms yields novel psychedelic molecules
Sintalica Bioscience Corp. announced it has cultivated, harvested and processed its first batch of psilocybin mushrooms and has synthesized psychedelic molecules with enhanced anti-inflammatory properties and no hallucinogenic effects.
FDA clears electrical muscle stimulator suit for neuromuscular injuries, disease
The FDA has granted 510(k) clearance to Neuro20 Technologies for its Neuro20 Pro System, a wearable whole-body electrical muscle stimulator suit, software and operating system for neuromuscular injuries and disease.
New auditory stimuli test shows promise in measuring cognitive function in severe MS
SAN DIEGO — A newly developed auditory-based test could assess and monitor cognitive function in previously untestable patients who are severely affected by MS, according to a poster at ACTRIMS 2023.
Recent evidence supports Epstein-Barr virus as ‘leading cause’ of MS
SAN DIEGO — Evidence over the past 10 years supports the role of Epstein-Barr virus in the development of MS, according to a presenter at ACTRIMS 2023.
Viz.ai, Johns Hopkins collaboration aids enrollment for NIH-funded brain injury trial
Viz.ai announced a collaboration with BIOS Clinical Trials Coordinating Center at Johns Hopkins University to facilitate patient enrollment for the NIH-funded Biomarker and Edema Attenuation in Intracerebral Hemorrhage study.
FDA approves Austedo XR for tardive dyskinesia, Huntington’s disease chorea
Teva Pharmaceuticals announced FDA approval of Austedo XR, a once-daily, extended-release formulation for adults with tardive dyskinesia and chorea associated with Huntington’s disease.
First patient enrolled in phase 1/2 study of hydroxyl dendrimer imaging agent
Ashvattha Therapeutics announced that the first patient has been enrolled in a phase 1/2 study to evaluate the ability of an imaging agent to cross the blood-brain barrier and target key markers of neuroinflammation.
Imperative Care launches digital health startup to improve stroke care, recovery
Medical technology company Imperative Care has announced the formation of Kandu Health, a digital health startup that aims to advance stroke recovery and post-acute stroke care through education, resources and guidance.
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read